📰 Guo Jun News
Guo Jun News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Guo Jun. Real-time updates on events, politics, business and more.
November 28, 2023
/PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, today announced its two Phase...
September 21, 2023
Xinhua to partner NAN on media relations. The Xinhua News Agency on Wednesday expressed its readiness to strengthen partnership
September 7, 2023
The Chinese news wire, Xinhua, yesterday expressed its interest in partnering with Media Trust Group, owners of Daily Trust titles, Aminiya, Trust TV and Trust Radio. The partnership is on delivery of robust and qualitative news. The outgoing Bureau Chief of Xinhua for Nigeria, Guo Jun, disclosed this in Abuja when he paid a courtesy…
July 1, 2023
* African governments owe three times more debt to Western banks, asset managers, and oil traders than to China, and are
June 17, 2023
Chinas strides in desert control an inspiration for Africa-
June 16, 2023
Interview: China-Africa scientific collaboration contributes to Africas anti-desertification drive, says Kenyan scholar-
June 14, 2023
Feature: China-backed project helps Nigeria build "green wall" against desertification-
June 5, 2023
/PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, announced the latest clinical...
June 5, 2023
YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, announced the latest clinical research results on disitamab vedotin (RC48) at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 2-6, 2023, in Chicago. Researchers tested disitamab vedotin and toripalimab in combination on...